feng-yu-shutterstock-com-patent-
Feng Yu / Shutterstock.com
3 March 2016AfricaDeborah Hart

Second medical use patents: why generics are in the dark

Second medical use claims have been around for a number of years, but until the recent decisions in the continuing Warner-Lambert v Sandoz case, there was relatively little guidance on how second medical use claims are interpreted and how infringement could be avoided. There are a number of ways generic companies can avoid infringement of second medical claims.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Africa
15 July 2025   Africa’s agricultural future is imperative to life and prosperity in the region—and the Arusha Protocol gives breeders the protection they need, explains the African Regional Intellectual Property Organization.
Africa
29 April 2025   Genomic innovations involve vast amounts of research, making patents, copyrights, and trade secrets vital, explains Olusola Tunmise-Ajani of Inventa International.
Africa
3 October 2023   Non-profit hails move but urges other big pharma companies to follow suit | To avoid litigation, manufacturers must ensure generic versions are of good quality, medically acceptable, and are used only in the selected low-and middle-income countries.